| BHCHX | THISX | BHCHX / THISX | |
| Total Expense Ratio | 0.85 | 0.68 | 125% |
| Annual Report Gross Expense Ratio | 0.95 | 0.68 | 140% |
| Fund Existence | 8 years | 10 years | - |
| Gain YTD | 4.096 | 6.820 | 60% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 500000 | 200% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 112M | 11.9B | 1% |
| Annual Yield % from dividends | 0.00 | 0.27 | - |
| Returns for 1 year | 24.14 | 14.57 | 166% |
| Returns for 3 years | 16.64 | -1.31 | -1,271% |
| Returns for 5 years | 3.05 | -18.73 | -16% |
| Returns for 10 years | N/A | 36.53 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTCX | 34.79 | N/A | N/A |
| Fidelity Advisor Biotechnology C | |||
| MRIEX | 13.89 | N/A | N/A |
| Meridian Hedged Equity Investor | |||
| FLUEX | 30.02 | N/A | N/A |
| Fidelity Advisor Stk Selec Lg Cp Val C | |||
| ERSMX | 28.29 | N/A | N/A |
| Eaton Vance Atlanta Capital SMID-Cap R | |||
| WBCIX | 18.53 | -0.09 | -0.48% |
| William Blair Small-Mid Cap Core I | |||